DaVita Inc.
- Last sale
- Nov 12, 2026 · -4.97%
- Market cap
- $10.97B
- 62.9M shares
- Filings
- 1,045
Q3 2026+6.5% FY25 yoy
Q3 2026−20.2% FY25 yoy
Q3 2026−2.2% FY25 yoy
Q3 2026derived−10.6% FY25 yoy
Q3 2026−8.3% FY25 yoy
Q3 2026−14.9% FY25 yoy
- $10.97B
- 11.9×
- 0.8×
- —
- 11.80%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $13,643,069,000 | reported | |
| FY 2024 | 2024-12-31 | $12,815,550,000 | reported | |
| FY 2023 | 2023-12-31 | $12,140,147,000 | reported | |
| FY 2022 | 2022-12-31 | $11,609,894,000 | reported | |
| FY 2021 | 2021-12-31 | $11,618,797,000 | reported | |
| FY 2020 | 2020-12-31 | $11,550,604,000 | reported | |
| FY 2019 | 2019-12-31 | $11,388,479,000 | reported | |
| FY 2018 | 2018-12-31 | $11,404,851,000 | reported | |
| FY 2017 | 2017-12-31 | $10,876,634,000 | reported | |
| FY 2016 | 2016-12-31 | $10,707,467,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | $0.00 | $1.31B | $1.31B | — | 66.80M sh | −16.5% | 99.8% |
| FY2024 | $0.00 | $1.39B | $1.39B | — | 80.00M sh | −8.8% | 94.5% |
| FY2023 | $0.00 | $272.22M | $272.22M | — | 87.70M sh | −3.0% | 18.3% |
| FY2022 | $0.00 | $802.23M | $802.23M | — | 90.40M sh | −6.1% | 83.5% |
| FY2021 | $0.00 | $1.54B | $1.54B | — | 96.30M sh | −12.0% | 119.3% |
Segments
Segments
LineFY2025ShareChange
U S Dialysis And Related Lab Services with Intersegment$11.79B86%+3.5%
U S Dialysis$11.73B86%+3.6%
Other Operating Segments with Intersegment$1.92B14%+27.3%
Other - Ancillary services$1.91B14%+27.7%
Total$13.64B
Miscellaneous health & allied services
DaVita Inc. is the largest of the 14 covered companies the SEC files under this code, by revenue. SIC 8090
CompanyRevenueGrowthNet marginMarket cap
DVADaVita Inc. (this company)$13.6B6.5%5.5%$11.0B
AGLagilon health, inc.$5.9B2.1%6.6%$1.9BPGNYProgyny, Inc.$1.3B10.4%4.5%$2.7BSHCSotera Health Co$1.2B5.7%6.7%$4.6BVMDViemed Healthcare, Inc.$270.3M20.5%5.5%$345.6MCCELCryo Cell International Inc$31.6M1.3%7.7%$34.5MMRAIMarpai, Inc.$18.1M35.8%91.5%$94.1MPFHOPacific Health Care Organization Inc$6.7M10.7%20.7%$16.4MMCTACharming Medical Ltd$4.8M22.7%0.5%$504.3MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
DaVita Inc. · CIK 927066 · Engraved from SEC EDGAR